|
|
||||||||
stimulates IL-6 production in cultured skeletal muscle
cells through activation of MAP kinase signaling pathway
and NF-
B
1 Department of Surgery, University of Cincinnati, Cincinnati, and Shriners Hospitals for Children, Cincinnati, Ohio 45267; and 2 Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Recent studies suggest that
the skeletal muscle may be a significant site of IL-6 production in
various conditions, including exercise, inflammation, hypoperfusion,
denervation, and local muscle injury. The mediators and molecular
mechanisms regulating muscle IL-6 production are poorly understood. We
tested the hypothesis that IL-6 production in muscle cells is regulated
by IL-1
and that mitogen-activated protein (MAP) kinase signaling
and NF-
B activation are involved in IL-1
-induced IL-6 production.
Cultured C2C12 cells, a mouse skeletal muscle cell line, were treated
with different concentrations (0.1-2 ng/ml) of IL-1
in the
absence or presence of the p38 MAP kinase inhibitor SB-208350 or the
p42/44 inhibitor PD-98059. Protein and gene expression of IL-6
were determined by ELISA and real-time PCR, respectively. NF-
B DNA
binding activity was determined by electrophoretic mobility shift assay
and by transfecting myocytes with a luciferase reporter plasmid
containing a promoter construct with multiple repeats of NF-
B
binding site. Treatment of myotubes with IL-1
resulted in a dose-
and time-dependent increase of IL-6 production accompanied by an
~25-fold increase in IL-6 mRNA levels. IL-1
stimulated NF-
B DNA
binding activity and gene activation. SB-208350 and PD-98059 inhibited
the increase in IL-6 production induced by IL-1
. The present results
support the concept that skeletal muscle is an important site of IL-6 production. In addition, the results suggest the IL-1
regulates muscle IL-6 production at least in part by activating the MAP kinase
pathway and NF-
B.
interleukin-6 production; cytokines; mitogen-activated protein
kinase; nuclear factor-
B
This article has been cited by other articles:
![]() |
M. KARALAKI, S. FILI, A. PHILIPPOU, and M. KOUTSILIERIS Muscle Regeneration: Cellular and Molecular Events In Vivo, September 1, 2009; 23(5): 779 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, J. S. Moylan, M. A. Chambers, J. Smith, and M. B. Reid Interleukin-1 stimulates catabolism in C2C12 myotubes Am J Physiol Cell Physiol, January 1, 2009; 297(3): C706 - C714. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Pedersen and M. A. Febbraio Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6 Physiol Rev, October 1, 2008; 88(4): 1379 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Juretic, P. Garcia-Huidobro, J. A. Iturrieta, E. Jaimovich, and N. Riveros Depolarization-induced slow Ca2+ transients stimulate transcription of IL-6 gene in skeletal muscle cells Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1428 - C1436. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Multiple Toll-like receptor ligands induce an IL-6 transcriptional response in skeletal myocytes Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R773 - R784. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Ho, M. F. Hirshman, Y. Li, D. Cai, J. R. Farmer, W. G. Aschenbach, C. A. Witczak, S. E. Shoelson, and L. J. Goodyear Regulation of I{kappa}B kinase and NF-{kappa}B in contracting adult rat skeletal muscle Am J Physiol Cell Physiol, October 1, 2005; 289(4): C794 - C801. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Frost, G. J. Nystrom, and C. H. Lang Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1153 - R1164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |